Home Health System Performance Tags

Health System Performance

The Peterson-KFF Health System Tracker is an online hub monitoring how well the U.S. health system is operating through key quality and cost measures. Visit the Tracker →

View the Latest: Health System Performance

Filter

List Grid

21 - 30 of 69 Results

  • How Does Cost Affect Access to Care?

    Feature

    This slideshow examines how cost and insurance affects people's access to care, including decisions to forgo or delay needed care and access to a usual source of care.

  • How Does U.S. Life Expectancy Compare to Other Countries?

    Feature

    This chart collection examines how life expectancy in the U.S. compares to that of other similarly large and wealthy countries. Between 2019 and 2022, the U.S. experienced a sharper decline and a slower rebound in life expectancy than peer countries, on average, due to increased mortality and premature death rates in the U.S. from the COVID-19 pandemic. In 2023, life expectancy in the U.S. returned to pre-pandemic levels, but remains lower than that of comparable countries.

  • Curbing The Ebola Outbreak: Are We on the Right Track?

    Event Date:
    Event

    The World Health Organization (WHO) recently declared a public health emergency due to the Ebola virus outbreak in West Africa, which has accounted for over 13,000 reported cases and 4,800 deaths. Some imported and locally acquired cases in health care workers have also been reported in the United States.

  • How has U.S. Spending on Health Care Changed Over Time?

    Feature

    This slideshow examines trends in U.S. health spending over time, including the share of household budgets devoted to health expenses and comparisons of out-of-pocket expenditures to money spent on insurance through 2021.

  • New Analysis Examines the $1.9 Billion Committed By the U.S. Government for the International Ebola Response To Date

    News Release

    A new Kaiser Family Foundation analysis finds government agencies so far report spending approximately $1.9 billion in funding to respond to the Ebola outbreak internationally. The majority of this spending was by USAID (49%), followed by the Department of Defense (33%), and the Centers for Disease Control and Prevention (18%). The U.S. government enacted $5.

  • What Testing Capacity Do We Need?

    Policy Watch

    This post looks at potential benchmarks for estimating the number of coronavirus tests needed in the United States and compares them to current national, and state level, testing levels.

  • What do we know about the burden of disease in the United States?

    Feature

    This slideshow examines disease burden in the United States and comparable countries as measured by Disability Adjusted Life Years (DALYs), which take into account years of life lost due to premature death and years of productive life lost to poor health or disability. Although the U.S. disease burden rate dropped 14 percent between 1990 and 2010. comparable countries saw an average decrease of 18 percent. In the United States, mental health and musculoskeletal disorders are the leading cause of years lost to disability, while cancer and circulatory diseases are the leading causes of years of life lost.

  • How Does the Quality of the U.S. Health System Compare to Other Countries?

    Feature

    This chart collection compare health outcomes, quality of care, and access to services between the U.S. and peer countries. While inconsistent and imperfect metrics make it difficult to firmly assess system-wide health quality in the U.S., a review of the available data prior to the onset of the COVID-19 pandemic suggests that in most of these measures, the U.S. has lagged behind comparably large and wealthy countries.